You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Raltitrexed

Showing 1 - 25 of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Nanchang (Fruquintinib)

Recruiting
  • Metastatic Colorectal Cancer
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Nov 1, 2023

Regorafenib, Raltitrexed, Colorectal Tumors Trial (Regorafenib, Raltitrexed)

Not yet recruiting
  • Regorafenib
  • +3 more
  • (no location specified)
Jun 24, 2022

Nasopharyngeal Carcinoma Trial in Wuhan (raltitrexed-cisplatin, Intensity-modulated radiotherapy (IMRT))

Completed
  • Nasopharyngeal Carcinoma
  • Wuhan, Hubei, China
    Hubei Cancer hospital
Feb 4, 2022

Advanced Colorectal Carcinoma Trial in Shanghai (Fruquintinib and raltitrexed, Fruquintinib)

Recruiting
  • Advanced Colorectal Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Oct 18, 2021

Cholangioadenoma Trial in Hangzhou (Raltitrexed combined with oxaplatin)

Recruiting
  • Cholangioadenoma
  • Raltitrexed combined with oxaplatin
  • Hangzhou, Zhejiang, China
    the Second Affiliated Hospital of Medical College of Zhejiang Un
Dec 6, 2021

Advanced Metastatic Colorectal Cancer Trial in Hangzhou (Raltitrexed, Irinotecan, Bevacizumab)

Recruiting
  • Advanced Metastatic Colorectal Cancer
  • Raltitrexed
  • +3 more
  • Hangzhou, Zhejiang, China
    the Second Affiliated Hospital of Medical College of Zhejiang Un
Dec 22, 2021

Colorectal Cancer Trial in Nanjing (Raltitrexed, Cetuximab)

Recruiting
  • Colorectal Cancer
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Institute & Hospital
Aug 27, 2021

Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Hepatocellular Carcinoma Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Mar 1, 2023

Rectal Tumors Malignant Trial in Beijing (radiation, drug, procedure)

Completed
  • Rectal Neoplasms Malignant
  • Preoperative radiation
  • +2 more
  • Beijing, Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Sep 1, 2021

Advanced Colorectal Cancer Trial in China (Raltitrexed, Irinotecan, Oxaliplatin)

Recruiting
  • Advanced Colorectal Cancer
  • Raltitrexed
  • +3 more
  • Nanjing, Jiangsu, China
  • +3 more
Aug 27, 2021

Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Liver, Cancer of, Primary Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Jan 18, 2023

Colorectal Cancer, Raltitrexed, HIPEC Trial in Shanghai (Raltitrexed)

Unknown status
  • Colorectal Cancer
  • +2 more
  • Raltitrexed
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 17, 2021

Esophagus Squamous Cell Carcinoma Trial in Huai'an (raltitrexed)

Active, not recruiting
  • Esophagus Squamous Cell Carcinoma
  • raltitrexed
  • Huai'an, Jiangsu, China
    Huai'an First Hospital
Apr 5, 2021

Colorectal Cancer Trial in Shanghai (HAIC, Fruquintinib, Tislelizumab)

Recruiting
  • Colorectal Cancer
  • HAIC
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 15, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Raltitrexed, Paclitaxel)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences
Jan 29, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin

Recruiting
  • Hepatocellular Carcinoma
  • Raltitrexed, oxaliplatin (SALOX) treatment
  • Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
May 17, 2022

Pancreatic Cancer, Chemo Effect Trial in Shanghai (raltitrexed for injection, nab-paclitaxel)

Recruiting
  • Pancreatic Cancer
  • Chemotherapy Effect
  • Shanghai, Shanghai, China
    Fudan University
Oct 3, 2020

Transarterial Chemoembolization, Hepatocellular Carcinoma Trial (cTACE-HAIC)

Unknown status
  • Transarterial Chemoembolization
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 17, 2020

Recurrent Colorectal Cancer Trial in Shanghai (Radiotherapy Combined With Raltitrexed and Irinotecan)

Unknown status
  • Recurrent Colorectal Cancer
  • Radiotherapy Combined With Raltitrexed and Irinotecan
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 31, 2020

Head and Neck Squamous Cell Carcinoma Trial in Dalian (Raltitrexed, Intensity Modulated Radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Raltitrexed
  • Intensity Modulated Radiotherapy
  • Dalian, Liaoning, China
    Lv Xiupeng
Aug 5, 2020

Hepatocellular Carcinoma Stage IIIa Trial in Hangzhou (Lenvatinib, mFOLFOX regimen, ROX regimen)

Enrolling by invitation
  • Hepatocellular Carcinoma Stage IIIa
  • Hangzhou, Zhejiang, China
    The Cancer Hospital of the University of Chinese Academy of Scie
Aug 12, 2021

Rectal Cancer Trial (Radiation therapy, Oxaliplatin, Raltitrexed)

Completed
Has Results
  • Rectal Cancer
  • Radiation therapy
  • +5 more
  • (no location specified)
Jan 13, 2021

Colorectal Cancer, Liver Metastasis Trial in China (Raltitrexed-based chemo, 5-fluorouracil-based chemo)

Terminated
  • Colorectal Cancer
  • Liver Metastasis
  • Raltitrexed-based chemotherapy
  • 5-fluorouracil-based chemotherapy
  • Guangzhou, Guangdong, China
  • +8 more
Jul 11, 2020

Metastatic Colorectal Cancer Trial in Montpellier (bevacizumab, oxaliplatin and 5FU combination, Bevacizumab, oxaliplatin and

Terminated
  • Metastatic Colorectal Cancer
  • bevacizumab, oxaliplatin and 5FU combination
  • Bevacizumab, oxaliplatin and raltitrexed combination
  • Montpellier, France
    Val d'Aurelle Cancer Institute
Dec 24, 2019

Hepatocellular Carcinoma Trial in Guangzhou (Hepatic arterial infusion chemo, Lenvatinib, Camrelizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Hepatic arterial infusion chemotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital of Southern Medical University
Aug 5, 2021